Could aspirin ease pain in kids with rare vein condition?

NCT ID NCT07663825

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding aspirin to a standard anti-inflammatory gel can reduce pain from blood clots in children aged 6 to 17 with superficial venous malformations. The trial will compare aspirin plus gel against a placebo plus gel over 14 days. Only 34 children will take part, making this a small, early investigation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Aspirin (acetylsalicylic acid) plus diclofenac gel
What this could lead to
If it works, this could point toward a standard way to manage painful clotting episodes in children with vein malformations.
What could go wrong
This is a very small, early-phase trial with only 34 children. It may not show a clear benefit, and aspirin carries risks like stomach upset or bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENOUS MALFORMATION, LOW FLOW are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AP-HM

    Marseille, France

  • AP-HP

    Paris, France

  • Centre Hospitalier Universitaire d'Angers

    Angers, France

  • Centre Hospitalier Universitaire de Brest

    Brest, France

  • Centre Hospitalier Universitaire de Nantes

    Nantes, France

  • Centre Hospitalier Universitaire de Rennes

    Rennes, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.